Global Clinical Next-generation Sequencing Market

Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report.

Table of Contents

Global Clinical Next-generation Sequencing MarketExecutive SummarySummaryMarket OverviewMarket OutlookCurrent Regulatory Status of NGS InstrumentsEvolution of NGS TestingNGS for Clinical versus Research ApplicationsMarket OutlookMarket Outlook on NGS Clinical Markets—Global NGS Clinical Landscape—ChinaNGS Clinical Landscape—United StatesUntapped Market for Clinical Applications of NGS—GlobalOpportunity Assessment for Clinical NGSUse of NGS Technology—Global NGS-based Companion Diagnostics a Near-term PossibilityBest Practices onReimbursement CoveragePoints to ConsiderCurrent Protocols for ReimbursementSuccess Stories of 3 Companies—What Drives Reimbursement?Genomic HealthVeracyteVeracyte (Illumina)Summary of Reimbursement Coverage Best PracticesBarriers to AdoptionTop BottlenecksLessons from Early AdoptersSurvey on Clinical NGSSurvey on Clinical NGS (continued)Key Conclusions and Future OutlookAppendix—Testing Trends by MethodAnalysis from the Genetic Test Repository (GTR)Test PurposeTest Method—NGS, Microarray, Sanger, and CGH BasedTests Offered By LocationTests Offered By Location (continued)List Price of Selected NGS-based Tests—United StatesSelected NGS-based Tests with Clinical SignificanceSelected NGS-based Tests with Clinical Significance (continued)Selected NGS-based Tests with Clinical Significance (continued)Profiles of Companies Offering NGS Clinical Tests—United StatesNGS Clinical Test Provider ProfilesNGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)NGS Clinical Test Provider Profiles (continued)Profiles of Companies Offering Direct-to-consumer Testing—Global List for DTC Genetic TestingList for DTC Genetic Testing (continued)List for DTC Genetic Testing (continued)List for DTC Genetic Testing (continued)List for DTC Genetic Testing (continued)FDA’s Warning Letters to ManufacturersList of Approved Companion Diagnostic KitsList of Approved Companion Diagnostic Kits (continued)Legal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition—Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.